that link shows completion not until the end of the year
mce-anchorStudy Design
Go to
Study Type : Interventional (Clinical Trial) 1 Estimated Enrollment : 60 participants 2 Intervention Model: Single Group Assignment 3 Masking: None (Open Label) 4 Primary Purpose: Treatment 5 Official Title: Phase I Study of Intra-peritoneal Cantrixil in Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. 6 Study Start Date : November 2016 7 Estimated Primary Completion Date : October 2018 8 Estimated Study Completion Date : December 2018
Re
- Forums
- ASX - By Stock
- KZA
- closer day by day
closer day by day, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity